Cargando…
Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter
Safe access to the most effective treatment options for Plasmodium vivax malaria are limited by the absence of accurate point-of-care testing to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common human genetic disorder. G6PD-deficient patients are at risk of life-threatenin...
Autores principales: | Chu, Cindy S, Bancone, Germana, Kelley, Maureen, Advani, Nicole, Domingo, Gonzalo J, Cutiongo-de la Paz, Eva M, van der Merwe, Nicole, Cohen, Jessica, Gerth-Guyette, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388194/ https://www.ncbi.nlm.nih.gov/pubmed/32766454 http://dx.doi.org/10.12688/wellcomeopenres.15700.2 |
Ejemplares similares
-
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening
por: Anderle, Athena, et al.
Publicado: (2018) -
Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development
por: Bancone, Germana, et al.
Publicado: (2017) -
Assessing the Operational Feasibility of Integrating Point-of-Care G6PD Testing into Plasmodium vivax Malaria Management in Vietnam
por: Gerth-Guyette, Emily, et al.
Publicado: (2023) -
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
por: Devine, Angela, et al.
Publicado: (2017) -
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021)